Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
90.62 USD | +0.81% | +2.30% | +10.00% |
04/09 | Transcript : Medtronic plc Presents at Wells Fargo 2024 Healthcare Conference, Sep-04-2024 11:55 AM | |
27/08 | Tranche Update on Medtronic plc's Equity Buyback Plan announced on June 23, 2017. | CI |
Projected Income Statement: Medtronic plc
Fiscal Period: April | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 28,913 | 30,117 | 31,686 | 31,227 | 32,364 | 33,575 | 35,166 | 36,891 |
Change | - | 4.16% | 5.21% | -1.45% | 3.64% | 3.74% | 4.74% | 4.91% |
EBITDA 1 | 8,472 | 8,096 | 9,830 | 9,294 | 9,226 | 9,699 | 10,383 | 11,084 |
Change | - | -4.44% | 21.42% | -5.45% | -0.73% | 5.12% | 7.06% | 6.75% |
EBIT 1 | 7,565 | 7,177 | 8,856 | 8,295 | 8,272 | 8,656 | 9,218 | 9,801 |
Change | - | -5.13% | 23.39% | -6.33% | -0.28% | 4.64% | 6.49% | 6.33% |
Interest Paid 1 | -1,092 | -925 | -553 | -636 | -719 | -695.5 | -682.2 | -651.2 |
Earnings before Tax (EBT) 1 | 4,055 | 3,895 | 5,517 | 5,364 | 4,837 | 6,384 | 7,180 | 7,957 |
Change | - | -3.95% | 41.64% | -2.77% | -9.82% | 31.99% | 12.46% | 10.82% |
Net income 1 | 4,789 | 3,606 | 5,039 | 3,758 | 3,676 | 5,145 | 5,653 | 6,068 |
Change | - | -24.7% | 39.74% | -25.42% | -2.18% | 39.95% | 9.89% | 7.35% |
Announcement Date | 21/05/20 | 27/05/21 | 26/05/22 | 25/05/23 | 23/05/24 | - | - | - |
Forecast Balance Sheet: Medtronic plc
Fiscal Period: April | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
Net Debt 1 | 20,657 | 22,796 | 20,400 | 22,821 | 23,740 | 21,045 | 19,372 | 17,346 |
Change | - | 10.35% | -10.51% | 11.87% | 4.03% | -11.35% | -7.95% | -10.46% |
Announcement Date | 21/05/20 | 27/05/21 | 26/05/22 | 25/05/23 | 23/05/24 | - | - | - |
Cash Flow Forecast: Medtronic plc
Fiscal Period: April | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
CAPEX 1 | 1,213 | 1,355 | 1,368 | 1,459 | 1,587 | 1,658 | 1,641 | 1,645 |
Change | - | 11.71% | 0.96% | 6.65% | 8.77% | 4.5% | -1.05% | 0.26% |
Free Cash Flow (FCF) 1 | 6,021 | 4,885 | 5,978 | 4,580 | 5,200 | 5,736 | 6,771 | 7,454 |
Change | - | -18.87% | 22.37% | -23.39% | 13.54% | 10.31% | 18.04% | 10.09% |
Announcement Date | 21/05/20 | 27/05/21 | 26/05/22 | 25/05/23 | 23/05/24 | - | - | - |
Forecast Financial Ratios: Medtronic plc
Fiscal Period: April | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
Profitability | ||||||||
EBITDA Margin (%) | 29.3% | 26.88% | 31.02% | 29.76% | 28.51% | 28.89% | 29.53% | 30.04% |
EBIT Margin (%) | 26.16% | 23.83% | 27.95% | 26.56% | 25.56% | 25.78% | 26.21% | 26.57% |
EBT Margin (%) | 14.02% | 12.93% | 17.41% | 17.18% | 14.95% | 19.01% | 20.42% | 21.57% |
Net margin (%) | 16.56% | 11.97% | 15.9% | 12.03% | 11.36% | 15.32% | 16.08% | 16.45% |
FCF margin (%) | 20.82% | 16.22% | 18.87% | 14.67% | 16.07% | 17.08% | 19.25% | 20.2% |
FCF / Net Income (%) | 125.73% | 135.47% | 118.63% | 121.87% | 141.46% | 111.49% | 119.77% | 122.83% |
Profitability | ||||||||
ROA | 6.88% | 6.54% | 5.48% | 7.74% | 7.65% | 6.78% | 7.16% | 7.27% |
ROE | 12.31% | 11.76% | 14.44% | 13.54% | 13.61% | 14% | 14.82% | 15.32% |
Financial Health | ||||||||
Leverage (Debt/EBITDA) | 2.44x | 2.82x | 2.08x | 2.46x | 2.57x | 2.17x | 1.87x | 1.57x |
Debt / Free cash flow | 3.43x | 4.67x | 3.41x | 4.98x | 4.57x | 3.67x | 2.86x | 2.33x |
Capital Intensity | ||||||||
CAPEX / Current Assets (%) | 4.2% | 4.5% | 4.32% | 4.67% | 4.9% | 4.94% | 4.67% | 4.46% |
CAPEX / EBITDA (%) | 14.32% | 16.74% | 13.92% | 15.7% | 17.2% | 17.1% | 15.81% | 14.84% |
CAPEX / FCF (%) | 20.15% | 27.74% | 22.88% | 31.86% | 30.52% | 28.91% | 24.24% | 22.07% |
Items per share | ||||||||
Cash flow per share 1 | 5.347 | 4.609 | 5.436 | 4.531 | 5.102 | 6.278 | 6.732 | 7.355 |
Change | - | -13.82% | 17.95% | -16.64% | 12.6% | 23.04% | 7.24% | 9.25% |
Dividend per Share 1 | 2.32 | 2.32 | 2.72 | 2.72 | 2.8 | 2.808 | 2.912 | 2.992 |
Change | - | 0% | 17.24% | 0% | 2.94% | 0.27% | 3.72% | 2.75% |
Book Value Per Share 1 | 37.84 | 38.23 | 39.49 | 38.69 | 38.29 | 38.64 | 40 | 41.4 |
Change | - | 1.01% | 3.31% | -2.04% | -1.02% | 0.91% | 3.52% | 3.5% |
EPS 1 | 3.54 | 2.66 | 3.73 | 2.82 | 2.76 | 4.028 | 4.422 | 4.792 |
Change | - | -24.86% | 40.23% | -24.4% | -2.13% | 45.93% | 9.78% | 8.38% |
Nbr of stocks (in thousands) | 13,40,166 | 13,48,073 | 13,41,539 | 13,30,424 | 13,27,823 | 12,82,490 | 12,82,490 | 12,82,490 |
Announcement Date | 21/05/20 | 27/05/21 | 26/05/22 | 25/05/23 | 23/05/24 | - | - | - |
2025 * | 2026 * | |
---|---|---|
P/E ratio | 22.3x | 20.3x |
PBR | 2.33x | 2.25x |
EV / Sales | 4.06x | 3.83x |
Yield | 3.12% | 3.24% |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
- Stock Market
- Equities
- MDT Stock
- Financials Medtronic plc
MarketScreener is also available in this country: United States.
Switch edition